Upgrade to SI Premium - Free Trial

Merck (MRK) PT Raised to $120 at Cantor Fitzgerald

October 27, 2022 12:47 PM
Cantor Fitzgerald analyst Louise Chen raised the price target on Merck (NYSE: MRK) to $120.00 (from $107.00) while maintaining an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles